TrialWire is the Innovation Award Winner in the Trial Recruitment Category in the 2025 Clinical Trials Arena Excellence Awards
TrialWire, a digital patient recruitment solution for clinical trial sponsors and contract research organizations (CROs), has emerged as the winner of the Innovation Award in the Trial Recruitment category at the 2025 Clinical Trials Arena Excellence Awards for its effective solutions addressing the critical issues of patient enrollment.
The Clinical Trials Arena Excellence Awards honor the most significant achievements and innovations in the pharmaceutical clinical trials industry. Powered by GlobalData’s business intelligence, the Awards recognize the people and companies leading change and shaping the future of the industry.
TrialWire won the award for effectively addressing the critical challenges of patient enrollment through its pioneering risk-share payment model, advanced artificial intelligence (AI)-driven technologies, and rapid recruitment capabilities, all of which enhance efficiency and accessibility in the clinical trials landscape.
Patient enrollment in clinical trials: Pioneering a risk-share payment model
One of the standout features of TrialWire’s approach is its introduction of the first risk-share payment model in digital patient recruitment, known as RapidRescue™. This is a unique risk-share model that ensures that clients incur costs only for successful enrollments, effectively mitigating financial risks associated with trial recruitment.
Traditional recruitment methods often require upfront payments for recruitment regardless of enrollment success, which can lead to significant financial burdens for sponsors, especially in high-stakes trials. By contrast, TrialWire’s model aligns the interests of both the company and its clients, fostering a collaborative environment that prioritizes successful patient engagement. This innovative approach builds client trust as well as incentivizes TrialWire to continuously refine its recruitment strategies.
Furthermore, the model allows sponsors to manage their budgets more effectively, and complete trials on time within budget. As a result, clients can conserve funding and progress with more trials without the fear of incurring excessive costs for unsuccessful enrollments, ultimately leading to a more dynamic and responsive clinical trial ecosystem.
Harnessing AI for enhanced patient engagement
TrialWire’s commitment to leveraging advanced technology is evident in its AI-driven solutions, which significantly streamline the recruitment process. The company’s proprietary AI Voice Agent service exemplifies this innovation, boosting patient engagement by 30%.
The service can accommodate varying levels of medical literacy and language proficiency. For example, many potential participants may struggle to understand complex medical terminology or may not be fluent in the primary language used in clinical trials. The AI Voice Agent addresses these challenges by facilitating conversations that are tailored to individual comprehension levels, ensuring that all potential participants can engage meaningfully with the recruitment process.
By automating various aspects of the recruitment process and utilizing predictive analytics, TrialWire’s AI-driven technologies not only expedite enrollment timelines, but also significantly lower the costs associated with traditional recruitment methods. By utilizing natural language processing and real-time interactions, TrialWire enhances the overall patient experience, making clinical trials more accessible to a diverse audience. This focus on inclusivity broadens the participant pool and contributes to more representative trial outcomes.
Additionally, the AI Voice Agent can handle multiple inquiries simultaneously, allowing for efficient screening of large numbers of candidates without compromising the quality of interaction.
Accelerating trial recruitment timelines with agility
TrialWire’s ability to initiate recruitment within 24 hours without requiring Institutional Review Board (IRB) or Ethics Committee (EC) submissions sets it apart from traditional methods. This agility allows sponsors and CROs to respond swiftly to changing trial dynamics and patient needs.
TrialWire can pivot quickly and begin recruitment efforts almost immediately if a trial experiences unexpected delays or if new patient populations needs to be targeted. Such rapid response capability is crucial in maintaining momentum in clinical trials, especially when timelines are tight and regulatory hurdles can often slow down progress.
Built on Salesforce Health Cloud, TrialWire ensures maximum security and compliance with stringent regulations such as HIPAA and GDPR. This robust infrastructure not only protects sensitive patient data, but also instills confidence among sponsors and participants alike. Coupled with robust data insights and real-time communication tools, TrialWire empowers clinical teams to make informed decisions throughout the enrollment lifecycle. By significantly reducing enrollment timelines and associated costs, TrialWire enhances overall trial efficiency, paving the way for faster access to new therapies for patients in need.
“We’re honored to receive this recognition from Clinical Trials Arena. This award reflects the dedication of our entire team – especially our brilliant software developers – who have built cutting-edge AI and algorithm-driven tools to radically improve how biotech companies recruit patients for clinical trials. Our platform was designed with both Sponsors and Sites in mind, delivering data-rich solutions that accelerate timelines and reduce inefficiencies.”
– Susan Fitzpatrick-Napier, Director, TrialWire
Susan added, “More than 80% of clinical trials fail to meet enrollment targets on time, resulting in budget blowouts, costly delays, and in some cases, trial termination. Beyond the financial impact – estimated at up to $8 million per day and over $30 billion annually – these delays ultimately prevent patients from accessing potentially life-saving therapies.”
“We’re changing that. By reengineering the speed and cost of recruitment, we’re helping Sponsors and CROs address one of the most persistent pain points in clinical research. With patient recruitment accounting for roughly 32% of total trial costs, the opportunity to innovate is both urgent and significant.”
Company Profile
TrialWire™ is the only pay-per-enrolled patient recruitment platform, purpose-built to address the biggest and most costly challenge facing clinical-stage biopharma companies – finding and enrolling patients.
TrialWire’s RapidRecruit™ solution combines advanced AI-driven technology, health algorithms, real-time communication tools, and robust data insights. TrialWire rapidly identifies, screens, and connects eligible participants to clinical trials, significantly reducing enrollment timelines and associated costs.
TrialWire on a mission to bridge the patient recruitment gap so more people can find and participate in important trials, so studies are recruited on time and approved drugs get to market faster.
Knowing that digital tools are the most powerful and effective, TrialWire has developed the best technology solution that ticks every box for patients and their privacy, to sponsors, CROs, and sites that comply with the strict clinical trials regulatory environments.
Contact Details
E-mail: [email protected]
Links
Website: https://trial-wire.com/
Check pricing here: https://trial-wire.com/quote/
